Results 211 to 220 of about 16,374 (258)

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025

British Journal of Clinical Pharmacology, EarlyView.
Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster, Juliana de Oliveira Costa, Tamara Y. Milder, Joanne Carson, Cade Shadbolt, Brendon L. Neuen, Clare Arnott, Andrew Wilson, Min Jun, Nicole Pratt, Sallie‐Anne Pearson   +10 more
wiley   +1 more source

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies, Elin Haf Davies, Dyfrig A. Hughes   +2 more
wiley   +1 more source

Evaluating the impact of a medical telephone helpline and the use of a structured initial assessment on demand for acute and emergency care in Germany: an ecological study using secondary data. [PDF]

BMJ Open
Zoch-Lesniak B, Steiger E, Kroll LE, von Stillfried DG.   +3 more
europepmc   +1 more source

Is equitable access to health and social care possible for Vietnamese older adults? Care providers' perspectives. [PDF]

Int Health
Vo MTH, Nakamura K, Tran DTH, Moncatar TJRT.   +3 more
europepmc   +1 more source

Public versus private healthcare systems in the OECD area- a broad evaluation of performance. [PDF]

Eur J Health Econ
Molander P.
europepmc   +1 more source

Improving Equitable Access to Antenatal Care in China: Challenges and Potential Innovative Approaches. [PDF]

China CDC Wkly
Dai Y, Shi X, Tariq O, Jiang L, Qu J, Wei Y, Zhao J, Ray N.   +7 more
europepmc   +1 more source

Health insurance policy enforcement and catastrophic health expenditure: a case study in Sichuan province, China. [PDF]

Front Public Health
Liu W, Huang G.
europepmc   +1 more source

[The work of a clinical diagnostic laboratory under compulsory medical insurance].

Klinicheskaia laboratornaia diagnostika, 2006
N N, Ivashchenko, E P, Petrenko, T P, Khripkova, N A, Slobodchikova   +3 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Medical Care under Compulsory Sickness Insurance in Germany

Social Service Review, 1947
This study1 of the Geman compul sory sickness insurance is based on twenty years of practical medical experience2 from the three medical view points involved. The purpose of this study is not to advocate the adoption of the German system in other countries but to present the facts regarding the German situation during the normal years.
openaire   +1 more source